IgA nephropathy in systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 25, Issue 3, 2007, Pages 467-469

  Corrado, Addolorata ^a,b   Quarta, Laura ^a   Di Palma, Anna Maria ^a   Gesualdo, Loreto ^a   Cantatore, Francesco Paolo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Rheumatology Clinic Mario Carrozzo   (Italy)

Author keywords

IgA nephropathy; Lupus; Lupus nephritis

Indexed keywords

ANTINUCLEAR ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA ANTIBODY; IMMUNOGLOBULIN A; PREDNISONE; RO ANTIBODY;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; BLOOD EXAMINATION; CASE REPORT; ERYTHEMA NODOSUM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; HYPERTENSION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LOW DRUG DOSE; MUSCLE WEAKNESS; PRIORITY JOURNAL; RASH; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

ADULT; BIOPSY; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 34447628343     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. HEMMEN T, PEREZ-CANTO A, DISTLER A, OFFERMANN G, BRAUN J: IgA nephropathy in a patient with Behçet syndrome - case report and review of literature. Br J Rheumatol 1997; 36: 696-9.
2. Mac-MOUNE LAI F, LI EKM, TANG NLS et al.: IgA nephropathy: a rare lesion in systemic lupus erythematosus. Med Pathol 1995; 8: 5-10.
3. BASILE C, SEMERARO A, MONTANARO A et al.: IgA nephropathy in a patient with systemic lupus erythematosus. Nephrol Dial Transplant 1998; 13: 1891-2.
4. LAM GKW, PETRI M: Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S120-S132.
5. IBELS LS, GAÖRY AZ: IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease and review of the literature. Medicine 1994; 73: 79-102.
6. CAMERON JS: Lupus nephritis. J Am Soc Nephrol 1999; 10: 413-24.
7. MIYAZAKI R, KURODA M, AKIYAMA T, OTANI I, TOFUKU Y, TAKEDA R: Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 1984; 21: 335-40.
8. RIFAI A, SMALL PA JR, TEGUE PO, AYOUB EM: Experimental IgA nephropathy. J Exp Med 1979; 150: 1161-73.
9. MONTEIRO RC, LEROY V, LAUNAY P et al.: Pathogénie de la maladie de Berger. Implications des immunogloblulines A et de leurs receptors. Medecine Sciences 2003; 19: 1233-41.
10. GUNNARSSON I, RONNELID J, LUNDBERG I, JACOBSON SH: Occurrence of anti-C1q antibodies in IgA nephropathy. Nephrol Dial Transplant 1997; 12: 2263-8.
11. WISNIESKI JJ, JONES SN: Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 1992; 148: 1396-403.
12. WANG MX, WALKER RG, KINCAID-SMITH P: Clinicopathologic associations of anti-endothelial cell antibodies in immunoglobulin A nephropathy and lupus nephritis. Am J Kidney Dis 1993; 22: 378-86.
13. TOPALOGLU R, BAKKALOGU A, SLINGSBY JH et al.: Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney Int 1996; 50: 635-42.
14. BOWNESS P, DAVIES KA, NORSWORTHY PJ et al.: Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 1994; 87: 455-64.